Exacerbations of COPD are associated with worsening of the airflow obstruction,
hospitalisation, reduced quality of life, disease progression and death. At least 70% of …

Patients with severe infections and a pre-existing indication for antithrombotic therapy, ie
antiplatelet agents, anticoagulant drugs, or their combinations, require integrated clinical …

Background: Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …

The association between nonalcoholic fatty liver disease (NAFLD) with cardiovascular and
cerebrovascular outcomes, as well as their clinical impact, has yet to be established in the …

Monkeypox virus has emerged in different parts of the world with varying clinical symptoms
and outcomes. To date, only a few studies have reported cardiac manifestations among …

To date, there were limited studies available on myocardial infarction (MI), and
consequently, the outcomes of patients with type 1 myocardial infarction (T1MI) compared to …

Background Statins are widely acknowledged for their application in patients with
hypercholesterolemia to reduce cardiovascular morbidity and mortality. More recently, their …

This scientific review paper explores international and country-specific healthcare
guidelines for non-communicable diseases with the highest burden among individuals aged …

Background: Sodium-glucose co-transporter 2 (SGLT2) inhibitors have been recommended
in the practice guidelines for the treatment of patients with heart failure with reduced ejection …

Aims The association between heart failure (HF) patients and the incidence of cancer is not
well understood, with conflicting results to date. The aim of this meta-analysis was to …